Annual Cash & Cash Equivalents
$61.46 M
+$17.59 M+40.12%
December 31, 2023
Summary
- As of February 10, 2025, FUSN annual cash & cash equivalents is $61.46 million, with the most recent change of +$17.59 million (+40.12%) on December 31, 2023.
- During the last 3 years, FUSN annual cash & cash equivalents has fallen by -$29.06 million (-32.11%).
Performance
FUSN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$27.79 M
-$33.67 M-54.78%
March 31, 2024
Summary
- As of February 10, 2025, FUSN quarterly cash and cash equivalents is $27.79 million, with the most recent change of -$33.67 million (-54.78%) on March 31, 2024.
- Over the past year, FUSN quarterly cash and cash equivalents has increased by +$1.00 million (+3.74%).
Performance
FUSN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FUSN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.1% | +3.7% |
| 3 y3 years | -32.1% | +3.7% |
| 5 y5 years | +113.6% | +3.7% |
FUSN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -28.6% | -73.8% | -3.6% |
| 5 y | 5-year | -32.1% | -28.6% | -91.3% | -3.6% |
| alltime | all time | -32.1% | -53.2% | -91.3% | -3.6% |
Fusion Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $27.79 M(-54.8%) |
| Dec 2023 | $61.46 M(+40.1%) | $61.46 M(+129.4%) |
| Sep 2023 | - | $26.79 M(-16.3%) |
| Jun 2023 | - | $32.02 M(-40.3%) |
| Mar 2023 | - | $53.62 M(+22.2%) |
| Dec 2022 | $43.86 M(-17.1%) | $43.86 M(-58.6%) |
| Sep 2022 | - | $106.05 M(+72.4%) |
| Jun 2022 | - | $61.52 M(+3.9%) |
| Mar 2022 | - | $59.21 M(+11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $52.90 M(-41.6%) | $52.90 M(+37.8%) |
| Sep 2021 | - | $38.38 M(+39.0%) |
| Jun 2021 | - | $27.61 M(-32.8%) |
| Mar 2021 | - | $41.07 M(-54.6%) |
| Dec 2020 | $90.52 M(+38.5%) | $90.52 M(-63.6%) |
| Sep 2020 | - | $248.79 M(-22.0%) |
| Jun 2020 | - | $318.89 M(+373.0%) |
| Mar 2020 | - | $67.42 M(+3.2%) |
| Dec 2019 | $65.34 M(+127.1%) | $65.34 M |
| Dec 2018 | $28.77 M | - |
FAQ
- What is Fusion Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Fusion Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Fusion Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of FUSN is $61.46 M
What is the all time high annual cash & cash equivalents for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high annual cash & cash equivalents is $90.52 M
What is Fusion Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, FUSN annual cash & cash equivalents has changed by +$17.59 M (+40.12%)
What is Fusion Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FUSN is $27.79 M
What is the all time high quarterly cash and cash equivalents for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high quarterly cash and cash equivalents is $318.89 M
What is Fusion Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, FUSN quarterly cash and cash equivalents has changed by +$1.00 M (+3.74%)